Alexander Kutikov, MD, FACS

Alexander Kutikov, MD, FACS, associate professor of Urologic Oncology, Fox Chase Cancer Center, discusses the options patients with a renal tumor have. Kutikov points out that not every mass needs to be resected and that patients need to understand the risks associated with each decision they make in the treatment process.

Videos

Kutikov points out that not every mass needs to be resected and that patients need to understand the risks associated with each decision they make in the treatment process.

Dr. Alexander Kutikov on Options Afforded to Kidney Cancer Patients

Kutikov and his colleagues feel it is best for patients to be treated with chemotherapy before surgery because the surgery continues to have limitations. About 20% to 30% of patients have a chance of recurrence. Neoadjuvant chemotherapy is also recommended due to the fact that there is no significant harm for patients.

Alexander Kutikov, MD, FACS, attending surgeon, Urologic Oncology, associate professor, Urologic Oncology, Fox Chase Cancer Center, discusses neoadjuvant chemotherapy for the treatment of patients with bladder cancer.

Alexander Kutikov, MD, FACS | Authors

Articles

Dr. Alexander Kutikov on Options Afforded to Kidney Cancer Patients

Neoadjuvant Chemotherapy for the Treatment of Patients With Bladder Cancer